Suppr超能文献

乙肝病毒核心蛋白增强细胞因子的产生。

HBV Core Protein Enhances Cytokine Production.

作者信息

Kanda Tatsuo, Wu Shuang, Sasaki Reina, Nakamura Masato, Haga Yuki, Jiang Xia, Nakamoto Shingo, Yokosuka Osamu

机构信息

Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.

出版信息

Diseases. 2015 Sep 17;3(3):213-220. doi: 10.3390/diseases3030213.

Abstract

Hepatitis B virus (HBV) infection, a cause of hepatocellular carcinoma (HCC), remains a serious global health concern. HCC development and human hepatocarcinogenesis are associated with hepatic inflammation caused by host interferons and cytokines. This article focused on the association between the HBV core protein, which is one of the HBV-encoding proteins, and cytokine production. The HBV core protein induced the production of interferons and cytokines in human hepatoma cells and in a mouse model. These factors may be responsible for persistent HBV infection and hepatocarcinogenesis. Inhibitors of programmed death (PD)-1 and HBV core and therapeutic vaccines including HBV core might be useful for the treatment of patients with chronic HBV infection. Inhibitors of HBV core, which is important for hepatic inflammation, could be helpful in preventing the progression of liver diseases in HBV-infected patients.

摘要

乙型肝炎病毒(HBV)感染是肝细胞癌(HCC)的一个病因,仍然是一个严重的全球健康问题。HCC的发展和人类肝癌发生与宿主干扰素和细胞因子引起的肝脏炎症有关。本文重点关注HBV编码蛋白之一的HBV核心蛋白与细胞因子产生之间的关联。HBV核心蛋白在人肝癌细胞和小鼠模型中诱导了干扰素和细胞因子的产生。这些因素可能是HBV持续感染和肝癌发生的原因。程序性死亡(PD)-1抑制剂、HBV核心抑制剂以及包括HBV核心在内的治疗性疫苗可能对慢性HBV感染患者的治疗有用。对肝脏炎症很重要的HBV核心抑制剂可能有助于预防HBV感染患者肝脏疾病的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a50/5548245/7913b7024a86/diseases-03-00213-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验